Physician profile
Peter J Fodor
NPI 1891772653
$2,051.90
in general payments reported to CMS, 2019-2025
27 companies · $512 in 2025
The $512 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $369 · 2020: $106 · 2021: $24.68 · 2022: $276 · 2023: $409 · 2024: $355 · 2025: $512.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,276.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,276.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $309.68 | 2019-2025 | Stravix Mesh, Renasys Go V2 Home, Pico |
| Tactile Systems Technology INC | $220.62 | 2020-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Treace Medical Concepts, INC. | $186.38 | 2022-2025 | |
| Organogenesis INC. | $168.59 | 2019-2024 | Affinity |
| Boston Scientific Corporation | $126.82 | 2019-2020 | |
| Averitas Pharma INC. | $126.37 | 2023-2025 | Qutenza |
| Kci USA, INC. | $123.44 | 2019-2023 | Promogran Prisma, Activ.A.C. |
| Convatec INC. | $82.57 | 2023-2025 | |
| Bioventus LLC | $68.60 | 2022-2025 | Exogen Ultrasound Bone Healing System |
| Vertex Pharmaceuticals Incorporated | $62.69 | 2024-2025 | |
| Paratek Pharmaceuticals, INC. | $57.58 | 2024-2025 | Nuzyra |
| Grt US Holding, INC. | $52.62 | 2022 | |
| Depuy Synthes Sales INC. | $51.00 | 2023-2024 | Motoband |
| Djo, LLC | $48.97 | 2019-2023 | Cmf |
| Novus Surgical Consultants | $45.10 | 2024-2025 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $44.57 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Solventum Corporation | $40.06 | 2024 | Activ.A.C., Promogran Prisma |
| Linvatec Corporation | $34.79 | 2019 | |
| Stryker Corporation | $34.07 | 2019 | |
| Nabriva Therapeutics, Plc | $32.41 | 2022 | |
| Ani Pharmaceuticals, INC. | $23.45 | 2025 | Purified Cortrophin Gel |
| Osiris Therapeutics INC. | $23.28 | 2019 | |
| Medtronic, INC. | $21.49 | 2024 | Intellis Adaptivestim |
| Orthofix Medical, INC. | $21.38 | 2025 | Physio-Stim |
| Acell, INC. | $17.57 | 2020 | |
| Sanara Medtech INC. | $14.79 | 2024 | Celleraterx |
| Kowa Pharmaceuticals America, INC. | $13.01 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Fodor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.